β Coefficient | SE | p Value | HR | 95% CI | ||
Lower | Upper | |||||
Crude model* | ||||||
Intervention | −0.01 | 0.17 | 0.95 | 0.99 | 0.70 | 1.39 |
Adjusted model—certain intention to return to work despite symptoms† | ||||||
Intervention | 0.72 | 0.27 | 0.01 | 2.05 | 1.22 | 3.45 |
Intention to return to work despite symptoms | 0.10 | 0.27 | 0.96 | 0.99 | 0.58 | 1.68 |
Sick leave in the past year (11 days–1 month vs 0–10 days) | −0.26 | 0.22 | 0.24 | 0.77 | 0.50 | 1.19 |
Sick leave in the past year (>1 month vs 0–10 days) | −0.61 | 0.24 | 0.01 | 0.55 | 0.34 | 0.88 |
Expected duration of absence (<1 month vs >1 month) | −0.41 | 0.21 | 0.05 | 0.66 | 0.44 | 0.99 |
Interaction intervention×intention to return to work despite symptoms | −0.97 | 0.37 | 0.01 | 0.38 | 0.18 | 0.79 |
Differences in RTW between the workplace intervention and usual care group RTW, return to work.
↵* The median time until full and lasting RTW was 96 days (IQR 52–193 days) in the workplace intervention group and 104 days (IQR 52–195 days) in the usual care group.
↵† The median time until full and lasting RTW for employees who at baseline intended to return to work despite symptoms was 55 days (IQR 27–89 days) in the workplace intervention group and 120 days (IQR 47–198 days) in the usual care group.